Showing results (671-680 of 2,556) with videos related to
Sort By:
Pageof 256
Therapeutics and Clinical Risk Management|October 31, 2017
Successful management of late-onset Streptococcus mitis endophthalmitisJinmann Chon, Moosang KimTherapeutics and Clinical Risk Management|February 2, 2018
Update on subcutaneous methotrexate for inflammatory arthritis and psoriasisGino Antonio Vena, Nicoletta Cassano, Florenzo IannoneTherapeutics and Clinical Risk Management|January 2, 2018
Clinical characteristics of cytomegalovirus colitis: a 15-year experience from a tertiary reference centerPuo-Hsien Le, Wey-Ran Lin, Chia-Jung Kuo, et al.Therapeutics and Clinical Risk Management|March 6, 2018
Comparison between the long-axis/in-plane and short-axis/out-of-plane approaches for ultrasound-guided vascular catheterization: an updated meta-analysis and trial sequential analysisChao Liu, Zhi Mao, Hongjun Kang, et al.Therapeutics and Clinical Risk Management|March 6, 2018
The frequency, risk factors, and complications of gastrointestinal dysfunction during enteral nutrition in critically ill patientsAyse Gulsah Atasever, Perihan Ergin Ozcan, Kamber Kasali, et al.Therapeutics and Clinical Risk Management|December 22, 2017
Incidence and risk factors of poor clinical outcomes in patients with cervical kyphosis after cervical surgery for spinal cord injuryYanwei Zhang, Jia Li, Yongqian Li, et al.Therapeutics and Clinical Risk Management|February 13, 2018
Off-label prescriptions in intensive care unit: the Chinese experienceLin Liu, Hong-Yu Yang, Yan Lou, et al.Therapeutics and Clinical Risk Management|November 10, 2017
The association of serum vitamin D concentration and ventricular dysfunction among patients with acute coronary syndromeKamal Khademvatani, Mirhosein Seyed Mohammadzad, Zahra Yekta, et al.Therapeutics and Clinical Risk Management|January 31, 2018
Raised serum uric acid is associated with higher bone mineral density in a cross-sectional study of a healthy Indian populationNeelam Kaushal, Divya Vohora, Rajinder K Jalali, et al.Therapeutics and Clinical Risk Management|December 22, 2018
Mepolizumab as the first targeted treatment for eosinophilic granulomatosis with polyangiitis: a review of current evidence and potential place in therapyPaola Faverio, Giulia Bonaiti, Francesco Bini, et al.Pageof 256